Type 1 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 1 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-03-09FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin R (insulin human) submitted by Eli Lilly and Company.
-
FDA approval · 2013-03-09FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin N (insulin human) submitted by Eli Lilly and Company.
-
FDA approval · 2013-03-09FDA Approved: NOVOLIN N — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for NOVOLIN N (human insulin) from Novo Nordisk, adding regulatory clearance for the product. This a…
-
CLINICAL_TRIALS trial_result · 2013-03-08Clinical Trial Update: Atorvastatin in New Onset Type 1 Diabetes Mellitus (T1DM) [Phase 2]
A Phase 2 trial evaluating atorvastatin for new-onset Type 1 diabetes mellitus has completed, with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-03-08Clinical Trial Update: Cardiopulmonary Fitness, Lung Function, Muscular Oxygen Saturation, and Quality of Life in T1DM
A completed clinical trial evaluating cardiopulmonary fitness, lung function, muscular oxygen saturation, and quality of life in people with…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-03-06Clinical Trial Update: Effects of Acute Intake of Caffeinated Beverages in Type 1 Diabetes [NA]
This clinical trial update summarizes the completion of a study examining the acute effects of caffeinated beverages on people with Type 1 d…
-
CLINICAL_TRIALS trial_result · 2013-03-01Clinical Trial Update: Safety and Pharmacokinetics of CBX129801 in Patients With Type 1 Diabetes [Phase 1, Phase 2]
This clinical trial update provides safety and pharmacokinetic data for CBX129801 in patients with Type 1 diabetes, reported across Phase 1 …
-
CLINICAL_TRIALS research · 2013-02-22Clinical Trial Update: Best Timing of Insulin Bolus Before Meals of Different Contents [NA]
The document reports a clinical trial assessing the best timing of insulin bolus administration before meals with different meal contents in…
-
FDA approval · 2013-02-21FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMULIN N (insulin human) from Eli Lilly and Company.
-
FDA label_change · 2013-02-15FDA Approved: APIDRA — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for APIDRA (insulin glulisine) submitted by sanofi-aventis U.S. LLC, resulting in a labeling update …
-
FDA approval · 2013-02-15FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for insulin lispro submitted by Eli Lilly and Company.
-
FDA approval · 2013-02-15FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMULIN N (insulin human) filed by Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Regular Physical Exercise Extends Honeymoon Phase in Type 1 Diabetes Subjects
A clinical trial update indicates that regular physical exercise may extend the honeymoon phase in individuals with Type 1 diabetes, though …
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Cognitive Function and Electrocardiogram (ECG) During Hypoglycemia and Blockade of the Renin-angiotensin System [NA]
A completed clinical trial evaluated cognitive function and ECG during hypoglycemia and examined the effects of renin-angiotensin system blo…
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Feasibility Study - Integrated Sensor and Infusion Set. Trial III [NA]
This update reports the completion of a feasibility trial evaluating an integrated sensor and infusion set for diabetes management.
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Feasibility Study of an Integrated Sensor and Infusion Set [NA]
This update reports the completion of a feasibility study evaluating an integrated sensor and infusion set for type 1 diabetes management.
-
CLINICAL_TRIALS research · 2013-02-05Clinical Trial Update: Collection of Performance Data From the Integrated Sensor and Infusion Set. TRIAL 4 [NA]
This clinical trial update describes the collection of performance data from an integrated sensor and infusion set in Trial 4 for diabetes. …
-
CLINICAL_TRIALS research · 2013-02-01Clinical Trial Update: Effects Of Gamma Aminobutyric Acid On The Progression Of New Onset Juvenile Type 1 Diabetes [NA]
This clinical trial assesses whether gamma-aminobutyric acid (GABA) influences the progression of new-onset juvenile Type 1 diabetes; the cu…
-
CLINICAL_TRIALS research · 2013-01-31Clinical Trial Update: Registry of Diabetes Patients in a Large Health Maintenance Organization in Israel
A registry study of diabetes patients in Maccabi Healthcare Services in Israel, currently enrolling by invitation.
-
FDA approval · 2013-01-30FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMALOG MIX50/50 KWIKPEN (insulin lispro) from Eli Lilly and Company.
-
FDA approval · 2013-01-30FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humalog Mix75/25 (insulin lispro) from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: Comparison of Technosphere Insulin Inhalation Powder & Subcutaneous Rapid-Acting Analog in Subjects With Type 1 Diabetes [Phase 1]
A Phase 1 study comparing inhaled Technosphere insulin powder with a subcutaneous rapid-acting insulin analog in individuals with Type 1 dia…
-
CLINICAL_TRIALS withdrawal · 2013-01-25Clinical Trial Update: Immunogenicity Study of Wockhardt's Insulin Lispro/Lispro Mix Basal Bolus Regimen in Type 1 Diabetics [Phase 3]
A Phase 3 immunogenicity trial of Wockhardt's insulin lispro/lispro mix basal-bolus regimen for Type 1 diabetes has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: Comparative Glucose Clamp Study of Wockhardt's Recombinant Insulin Analog Glargine(Glaritus) With Lantus in T1DM [Phase 1]
Phase 1 glucose clamp study comparing Wockhardt's insulin glargine analog Glaritus with Lantus in type 1 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: Comparison of Insulin Detemir and Insulin Aspart in 2 Separate Injections Twice Daily to Extemporaneous Mixing Injection Regimen Twice Daily - The Paediatric Mixing Trial [Phase 4]
Phase 4 pediatric trial comparing two separate injections of insulin detemir and insulin aspart twice daily to a twice-daily extemporaneous …